Jennifer Reese

Jennifer Reese serves as the Senior Vice President and Head of Medical Affairs at Sentynl Therapeutics, Inc. since September 2022. With extensive experience in medical affairs, Jennifer previously held the position of Senior Vice President of Medical Affairs at Spero Therapeutics from 2019 to 2022, where responsibilities included developing medical strategy, overseeing real-world evidence generation, and engaging with key medical experts. Prior roles include Vice President of Medical Affairs at Melinta Therapeutics, Vice President of Global Health Science at The Medicines Company, Executive Director of External Medical Affairs at Actavis plc, and various positions at Forest Laboratories. Jennifer Reese holds a Bachelor's Degree in Pharmacy from the University of North Carolina at Chapel Hill and a Doctor of Pharmacy (Pharm.D.) from the Massachusetts College of Pharmacy and Health Sciences.